Anaam F.*, Eptissam Y. Pirko, Adawia F. Abaas and Burooj M. Razooqi Al-Aajem


Background: Diabetes mellitus is a serious public health problem, S. aureus is the most common bacteria isolated from ulceration of diabetic patients, and increase the risk of S. aureus carriage in patients with diabetes may reflect association between diabetes and bacterial carriers. The aim of the study was to estimation rate of S. aureus carrier in diabetic's patients type-2 and determine antimicrobial effect of Gliotoxin on previous bacterial carriage in type-2 diabetes. Patients and Methods: The study was conducted on 450 diabetics' patients, attended the out patients clinic in Baquba Teaching Hospital, their ages ranged from15-65years, with mean age of 36.15, who were randomly selected, during the period from May 2016 to April 2017, patients were classified into two groups according to type of diabetes, group1 included: 184 with type1-diabetes, and group2: included 266 with type2-diabetes, 97 patients with foot ulcers. Swabs were taken from anterior nares, toe and axillae for each diabetic patient type-2, identified based on standard bacteriological methods. Using Kirby-Bauer method for detection antibacterial effect of Gliotoxin. Results: The results showed rates of bacterial carriage in anterior nares of type-2diabetic patients without complications were (11.4%), (4.4%), respectively for S. aureus and MRSA, in type-2 diabetes with complications were (8.6%),(2.1%) respectively for S. aureus and MRSA. The study showed the Aspergillus fumigatus Gliotoxin was effective against S. aureus and MRSA carrier in diabetics patients type-2 with foot ulcer, for S. aureus inhibition diameter was (20.50, 16.40, 12.20) mm for different concentrations of Gliotoxin, to MRSA was (8.25, 6.1, 4.20) mm. Its antibacterial effect was directly proportional with its concentration According to the values of MIC & MBC, the results revealed that the Gliotoxin of Aspergillus fumigatus were more effective as antibacterial agent against S. aureus and MRSA. Conclusion: Increasing rate of S. aureus carrier in diabetic patient's type-2 which lead to a significantly increased risk of bacterial infections. Gliotoxin was effective as antibacterial agent against S. aureus in type-2diabetis.

Keywords: Diabetes type-1, diabetes type-2, S. aureus nasal carriage, Aspergillus fumigatus, Gliotoxin (GT).

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2022 Issue has been successfully launched on 1 May 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction